0 CHECKOUT

PRODUCT FILTERS

REGION

80
28
22
16
11

COUNTRY

28
4
4
2
2

CATEGORIES

  • 180
  • 101
  • 93
  • 51
  • 41
  • 38
  • 31
  • 25
  • 18
  • 11
  • 9
  • 8
  • 5
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

146
358
463
606

PUBLISHED

5
26
90
606

PRODUCT TYPE

397
181
26
1
1

Search for: "Breast Cancer Therapy Area Pipeline Report"

606 Products

US Breast Cancer Therapy Market Opportunity Analysis

Breast cancer is a type of malignancy that affects breast tissue and its incidences are increasing across the globe. It is also one of the most common cancers in American women which cause high morbidity...

Published:  July 2015
Price:  From

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

"Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options" provides in-depth analysis of breast cancer market within the Asia-Pacific...

Published:  May 2014
Price:  From

Cancer Gene Therapy Market Analysis

The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases The initial studies of gene...

Published:  March 2014
Price:  From

Metastatic Breast Cancer - Pipeline Review, H2 2014

Metastatic Breast Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Breast Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline. This...

Published:  November 2014
Price:  From

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

The leading business intelligence provider, has released its latest research, '‘Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance...

Published:  June 2014
Price:  From

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

Published:  September 2015
Price:  From
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Review, H1 2014

Metastatic Breast Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2014’, provides an overview of the Metastatic Breast Cancer’s therapeutic...

Published:  March 2014
Price:  From

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

Published:  September 2015
Price:  From
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Breast Cancer - Pipeline Review, H1 2014

Breast Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report...

Published:  March 2014
Price:  From

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

The current market for breast cancer consists of five monoclonal Antibodies (mAbs), three of which are targeted at the Human Epidermal growth factor Receptor 2 (HER-2) protein Four are aimed at improving...

Published:  October 2013
Price:  From

Metastatic Breast Cancer - Pipeline Review, H1 2015

Metastatic Breast Cancer - Pipeline Review, H1 2015 Summary the, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline. This...

Published:  June 2015
Price:  From

Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

GBI Research, the leading business intelligence provider, has released its latest research, ""Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars...

Published:  April 2013
Price:  From

Breast Cancer - Pipeline Review, H2 2014

Breast Cancer - Pipeline Review, H2 2014 Summary This, ‘Breast Cancer - Pipeline Review, H2 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  November 2014
Price:  From

Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies

This report provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders, Infection,...

Published:  February 2011
Price:  From

Analytical Tool - Breast Cancer

"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at the same time...

Published:  March 2014
Price: 

Oncology Intelligence: A Comprehensive Report for Decision Making

Oncology Intelligence Report 2013 provides complete landscape on cancer drug development, by bringing more authentic data under evaluation and is designed in a manner to keep knowledge instant, clear...

Published:  January 2013
Price: 
Oncology Intelligence: A Comprehensive Report for Decision Making Oncology Intelligence: A Comprehensive Report for Decision Making - Product Thumbnail Image

Breast Cancer: New targeted therapies transform treatment - KOL Insight

The introduction of targeted therapies revolutionised the breast cancer market, widening clinical options and bringing improved survival rates and lower side effects for patients Now the sector is set...

Published:  February 2014
Price:  From

Global & USA Cancer Immunotherapy Market Analysis to 2020

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR)...

Published:  April 2015
Price:  From

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

Published:  September 2015
Price:  From
Biomarkers - Technologies, Markets and Companies Biomarkers - Technologies, Markets and Companies - Product Thumbnail Image

Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake

GBI Research, the leading business intelligence provider, has released its latest research “Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival,...

Published:  March 2013
Price:  From
Loading Indicator

Our Clients

  • NBC Universal Inc.
  • Samsung Group Ltd.
  • E.ON SE
  • DHL International GmbH
  • University of Cambridge
  • Kone Oyj
  • BP Plc.